BDPT — BIOADAPTIVES, INC.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1575142 ·
Last close
$0.01
Market Cap
$132.1K
52W High
$0.02
52W Low
$0.01
ADV30
55,640
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 5,514 | 4,113 | -198,218 | -111,086 | 135,949 | 73,606 | 2,272,091 |
| Dec 2025 | 10,427 | 7,583 | -248,117 | -823,346 | 225,901 | 158,445 | 2,355,957 |
| Sep 2025 | 4,632 | 3,851 | -265,689 | -379,502 | 124,360 | 59,273 | 1,589,570 |
| Jun 2025 | 3,219 | 1,063 | -279,219 | -157,914 | 272,515 | 210,582 | 1,407,813 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-516,025
Investing CF
$0
Financing CF
$549,115
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.08
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-10,721,204
Inventory
$44,706
Receivables
$0
ST Investments
—
EBIT TTM
$-1,487,018
Pretax Income TTM
$-1,557,898
Interest Exp TTM
$70,880
Analysts
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 18,278 | -1,042,173 | -1,557,898 | 225,901 | 2,355,957 | — | -516,025 |
| Dec 2024 | 12,669 | -520,740 | -899,161 | 261,885 | 1,725,803 | — | -249,517 |
| Dec 2023 | 28,565 | -228,921 | -712,466 | 103,998 | 1,750,629 | — | -223,773 |
| Dec 2022 | 17,176 | -421,900 | -895,570 | 37,314 | 1,488,815 | — | -227,259 |
| Dec 2021 | — | — | — | — | — | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| ADTX | Aditxt, Inc. | $129.8K | $0.25 | — |
| GCAN | Greater Cannabis Company, Inc. | $137.0K | $0.14 | — |
| RGBP | Regen BioPharma Inc | $153.6K | $0.00 | — |
| BNIGF | Beroni Group Ltd | $180.0K | $0.01 | — |
| IOBTQ | IO Biotech, Inc. | $215.8K | $0.00 | — |
News headlines (Yahoo Finance, 1h cache)
BioAdaptives Launches MyndSystem™ Website — The First Supplement Platform Designed to Support Both Daytime Cognitive Performance and Overnight Brain Recovery
2026-05-20 20:15 · Yahoo
BioAdaptives, Inc. Launches MyndRenew™ to Complete the 24-Hour Brain Performance Cycle
2026-05-06 12:54 · Yahoo
BioAdaptives introduces MyndSystem™, an integrated Neuro-Performance & Repair system for day and night
2026-04-28 14:00 · Yahoo
BioAdaptives® Announces Commercial Launch of MyndMed™ Following Successful Pilot Testing
2025-10-07 15:48 · Yahoo
BioAdaptives’ MyndMed™ Receives Full Clearance from TruShield™, Meeting UFC and WADA Standards for Athlete Safety
2025-08-20 15:54 · Yahoo
BioAdaptives Announces National Launch of NeuroRush™ — A Cutting-Edge Adaptogenic Nootropic for Mental Clarity, Focus, and Resilience
2025-07-16 12:58 · Yahoo
BioAdaptives Announces National Launch of Pawpa™ Regen
2025-06-24 14:31 · Yahoo
BioAdaptives® PawPa™ Regen Provides Breakthrough Stem Cell Support for Pets, Backed by Clinically Proven APBAR® Scale Improvements
2025-05-28 13:15 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.